综合一区欧美国产,99国产麻豆免费精品,九九精品黄色录像,亚洲激情青青草,久久亚洲熟妇熟,中文字幕av在线播放,国产一区二区卡,九九久久国产精品,久久精品视频免费

Stem cell treatment due for a checkup

Updated: 2012-01-11 09:09

By Shan Juan (

China Daily

)

  Comments() Print Mail Large Medium  Small

BEIJING - China's top health authority will strictly regulate the cutting-edge stem cell treatment, which attracts thousands of patients from abroad each year, to ensure patient safety and the orderly development of the technology.

A one-year overhaul highlighting self-examination among practitioners will be launched to detect and eliminate irregularities surrounding the issue, said Deng Haihua, spokesman of the Ministry of Health at a news conference on Tuesday.

Stem cell treatment due for a checkup

"All medical research and clinical practices of stem cell therapy without approval from the ministry and the State Food and Drug Administration will be put to an end after the overhaul," he told China Daily.

Largely due to concerns over ethics, treatment efficacy, and a lack of relative laws and regulations, the health authority has never approved clinical use of the therapy on the mainland, Deng stressed.

However, the demand and practice of the treatment have existed for a long time and are rapidly increasing, said Yang Jian, CEO of the Shanghai Medical Tourism Products and Promotion Platform.

Industry analysis shows that at least 10,000 patients from other countries come to the mainland for the costly procedure each year and roughly 100 facilities are offering the service.

Yang said some hospitals exploit regulatory loopholes to carry out the controversial therapy, which experts warn has no guarantee for safety and efficacy, he added.

In China, stem cell therapy is mainly used to treat diabetes, spinal cord injury, cerebral palsy, brain injury and stroke.

A nurse surnamed Qiao with the stem cell transplantation department of the General Hospital of Chinese People's Armed Police Forces told China Daily on Tuesday that they now have 80 patients, including 10 expats, undergoing stem cell treatment.

Since 2003, Qiao's department has treated more than 4,000 patients from 15 countries.

Asked how the overhaul would affect their business, she said because of the hospital's affiliation with the Armed Police, it would not be subject to management by the Ministry of Health.

Many hospitals with a military background are carrying out the therapy, said Qiu Renzong, a leading bioethicist with the Chinese Academy of Social Sciences.

To date, only adult stem cells sourced from bone marrow and umbilical cords for treating blood cancer have been proven safe and effective, he said.

More scientific data in terms of safety and efficacy is needed before stem cell treatment can be applied to humans, according to the World Health Organization.

Wang Qingyun contributed to this story.

百色市| 北辰区| 天峻县| 贞丰县| 平潭县| 三台县| 武功县| 山东| 阿拉善右旗| 赣榆县| 兴仁县| 车致| 洪雅县| 清丰县| 怀宁县| 乌拉特前旗| 陆丰市| 惠安县| 阿巴嘎旗| 密云县| 兰州市| 湖口县| 华宁县| 清苑县| 雅安市| 泰州市| 洛阳市| 定兴县| 郸城县| 泰来县| 廉江市| 梅州市| 大余县| 鹤岗市| 宣城市| 辽宁省| 巴楚县| 洛阳市| 玉树县| 沅陵县| 搜索|